{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T01:30:36Z","timestamp":1778808636529,"version":"3.51.4"},"reference-count":41,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,6,29]],"date-time":"2023-06-29T00:00:00Z","timestamp":1687996800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pediatr."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Atypical hemolytic uremic syndrome (aHUS) with diacylglycerol kinase epsilon (<jats:italic>DGKE<\/jats:italic>) gene variant is a rare variant of thrombotic microangiopathy (TMA). The information on the clinical features, management and long-term outcomes of <jats:italic>DGKE<\/jats:italic>-aHUS patients have not yet been fully elucidated. The aim of this study was to report a novel variant of the <jats:italic>DGKE<\/jats:italic> gene in a Chinese population with aHUS.<\/jats:p><\/jats:sec><jats:sec><jats:title>Case presentation<\/jats:title><jats:p>The present work reports a 7-month-old boy with aHUS, possibly triggered by gastrointestinal infection, without complement activation, with little response to plasma therapy and nephroprotective measures. The patient died during the 8th week of his hospital stay. The causes of death were intracranial hemorrhage and multiorgan dysfunction. Comprehensive WES of peripheral blood-derived DNA revealed two heterozygous variations in the <jats:italic>DGKE<\/jats:italic> exon region: NM_003647.2, c.610dup, p.Thr204Asnfs*4 and deletion of exons 4\u20136.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>This case suggest that atypical HUS with <jats:italic>DGKE<\/jats:italic> gene variant has a poor prognosis with a high mortality rate, which typically manifests in the first year of life and presents as a systemic disease with early-onset HUS with rapidly worsening renal function and chronic proteinuria. There is no specific treatment for <jats:italic>DGKE<\/jats:italic>-aHUS. There have an uncertain benefit of plasma therapy for <jats:italic>DGKE<\/jats:italic>-aHUS patients. The literature demonstrated that anti-complement therapy showed benefits for <jats:italic>DGKE<\/jats:italic>-aHUS with complement activation and autoantibodies during the overt TMA presentation but did not prevent TMA relapses. Early diagnosis and treatment may prevent complications and improve prognosis.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fped.2023.1162974","type":"journal-article","created":{"date-parts":[[2023,6,29]],"date-time":"2023-06-29T17:12:23Z","timestamp":1688058743000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":4,"title":["Clinical features and management of atypical hemolytic uremic syndrome patient with DGKE gene variants: a case report"],"prefix":"10.3389","volume":"11","author":[{"given":"Xiaomei","family":"Dai","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qiang","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hanyun","family":"Tang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ruyue","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yun","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yunyan","family":"Shen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ningxun","family":"Cui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhongqin","family":"Hong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanhong","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaozhong","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2023,6,29]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1038\/ng.2622","article-title":"DGKE and atypical HUS","volume":"45","author":"Quaggin","year":"2013","journal-title":"Nat Genet"},{"key":"B2","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1038\/ng.2590","article-title":"Recessive mutations in DGKE cause atypical hemolytic-uremic syndrome","volume":"45","author":"Lemaire","year":"2013","journal-title":"Nat Genet"},{"key":"B3","doi-asserted-by":"publisher","first-page":"1967","DOI":"10.1007\/s00467-021-05370-8","article-title":"Thrombotic microangiopathy in children","volume":"37","author":"Palma","year":"2022","journal-title":"Pediatr Nephrol"},{"key":"B4","doi-asserted-by":"publisher","first-page":"99","DOI":"10.5551\/jat.RV17026","article-title":"Pathogenesis of atypical hemolytic uremic syndrome","volume":"26","author":"Yoshida","year":"2019","journal-title":"J Atheroscler Thromb"},{"key":"B5","doi-asserted-by":"publisher","first-page":"F895","DOI":"10.1152\/ajprenal.00431.2015","article-title":"Loss of diacylglycerol kinase epsilon in mice causes endothelial distress and impairs glomerular Cox-2 and PGE2 production","volume":"310","author":"Zhu","year":"2016","journal-title":"Am J Physiol Renal Physiol"},{"key":"B6","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.1182\/blood-2014-06-579953","article-title":"Loss of DGK epsilon induces endothelial cell activation and death independently of complement activation","volume":"125","author":"Bruneau","year":"2015","journal-title":"Blood"},{"key":"B7","doi-asserted-by":"publisher","first-page":"1611","DOI":"10.2215\/CJN.01640214","article-title":"Complement mutations in diacylglycerol kinase-epsilon-associated atypical hemolytic uremic syndrome","volume":"9","author":"Sanchez","year":"2014","journal-title":"Clin J Am Soc Nephrol"},{"key":"B8","doi-asserted-by":"publisher","first-page":"103953","DOI":"10.1016\/j.ejmg.2020.103953","article-title":"Various phenotypes of disease associated with mutated DGKE gene","volume":"63","author":"Bezdicka","year":"2020","journal-title":"Eur J Med Genet"},{"key":"B9","doi-asserted-by":"publisher","first-page":"bcr2017222560","DOI":"10.1136\/bcr-2017-222560","article-title":"Atypical presentation of atypical haemolytic uraemic syndrome","volume":"2018","author":"Basak","year":"2018","journal-title":"BMJ Case Rep"},{"key":"B10","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1159\/000487609","article-title":"Atypical hemolytic uremic syndrome in children aged &lt;2 years","volume":"139","author":"\u00c7akar","year":"2018","journal-title":"Nephron"},{"key":"B11","doi-asserted-by":"publisher","first-page":"1237","DOI":"10.1111\/jpc.14390","article-title":"Eculizumab in paediatric atypical haemolytic uraemic syndrome: lessons learned from a single-centre experience in the United Arab Emirates","volume":"55","author":"Kumar","year":"2019","journal-title":"J Paediatr Child Health"},{"key":"B12","doi-asserted-by":"publisher","first-page":"kez063.052","DOI":"10.1093\/rheumatology\/kez063.052","article-title":"Atypical hemolytic uremic syndrome with diacylglycerol kinase-e mutation in a patient with microscopic polyangiitis: a possible relationship via complement activation?","volume":"58","author":"Bulanov","year":"2019","journal-title":"Rheumatology"},{"key":"B13","doi-asserted-by":"publisher","first-page":"101","DOI":"10.4103\/AJPN.AJPN_27_19","article-title":"Atypical hemolytic uremic syndrome with diacylglycerol kinase epsilon (DGKE) gene mutation","volume":"2","author":"Sharma","year":"2019","journal-title":"Asian J Pediatr Nephrol"},{"key":"B14","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1093\/ckj\/sfz043","article-title":"Diacylglycerol kinase epsilon nephropathy: late diagnosis and therapeutic implications","volume":"12","author":"Holanda","year":"2019","journal-title":"Clin Kidney J"},{"key":"B15","doi-asserted-by":"publisher","first-page":"165","DOI":"10.3389\/fped.2020.00165","article-title":"Interpretation of autosomal recessive kidney diseases with \u201cpresumed homozygous\u201d pathogenic variants should consider technical pitfalls","volume":"8","author":"Deng","year":"2020","journal-title":"Front Pediatr"},{"key":"B16","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1007\/s12328-019-01052-z","article-title":"Eculizumab treatment of thrombotic microangiopathy in a patient with ulcerative colitis","volume":"13","author":"\u00d8zbay","year":"2020","journal-title":"Clin J Gastroenterol"},{"key":"B17","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1159\/000510612","article-title":"Improved renal recovery with eculizumab therapy among children with high prevalence of mutation-associated atypical hemolytic uremic syndrome: a retrospective cohort study","volume":"45","author":"Bamhraz","year":"2020","journal-title":"Kidney Blood Press Res"},{"key":"B18","doi-asserted-by":"publisher","first-page":"1739","DOI":"10.1007\/s00431-020-03666-9","article-title":"Molecular basis and outcomes of atypical haemolytic uraemic syndrome in Czech children","volume":"179","author":"\u0160tolbov\u00e1","year":"2020","journal-title":"Eur J Pediatr"},{"key":"B19","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1186\/s12881-020-01097-9","article-title":"Whole exome sequencing revealed a novel homozygous variant in the DGKE catalytic domain: a case report of familial hemolytic uremic syndrome","volume":"21","author":"Gholizad-Kolveiri","year":"2020","journal-title":"BMC Med Genet"},{"key":"B20","doi-asserted-by":"publisher","first-page":"1260","DOI":"10.1016\/j.kint.2020.01.045","article-title":"Long-term outcomes and response to treatment in diacylglycerol kinase epsilon nephropathy","volume":"97","author":"Brocklebank","year":"2020","journal-title":"Kidney Int"},{"key":"B21","doi-asserted-by":"publisher","first-page":"1331","DOI":"10.1007\/s40620-020-00925-8","article-title":"Atypical hemolytic uremic syndrome due to DGKE mutation and response to eculizumab: lessons for the clinical nephrologist","volume":"34","author":"Husain","year":"2021","journal-title":"J Nephrol"},{"key":"B22","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.cca.2021.02.021","article-title":"Cyclosporine A relieved proteinuria and hypoproteinemia in DGKE nephropathy","volume":"518","author":"Fu","year":"2021","journal-title":"Clin Chim Acta"},{"key":"B23","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1186\/s12882-021-02352-8","article-title":"A patient with a homozygous diacylglycerol kinase epsilon (DGKE) gene mutation with atypical haemolytic uraemic syndrome and low C3 responded well to eculizumab: a case report","volume":"22","author":"Alabdulqader","year":"2021","journal-title":"BMC Nephrol"},{"key":"B24","doi-asserted-by":"publisher","first-page":"986","DOI":"10.24953\/turkjped.2021.06.006","article-title":"Could plasma based therapies still be considered in selected cases with atypical hemolytic uremic syndrome?","volume":"63","author":"\u00d6zl\u00fc","year":"2021","journal-title":"Turk J Pediatr"},{"key":"B25","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1590\/2175-8239-JBN-2020-0199","article-title":"Genetic atypical hemolytic uremic syndrome in children: a 20-year experience from a tertiary center","volume":"43","author":"Maximiano","year":"2021","journal-title":"J Bras Nefrol"},{"key":"B26","doi-asserted-by":"publisher","first-page":"1500","DOI":"10.1016\/j.kint.2021.02.032","article-title":"Outcome of diacylglycerol kinase epsilon-mediated hemolytic uremic syndrome in an infant","volume":"99","author":"Koyun","year":"2021","journal-title":"Kidney Int"},{"key":"B27","doi-asserted-by":"publisher","first-page":"3066","DOI":"10.1681\/ASN.2017010031","article-title":"The phenotypic Spectrum of nephropathies associated with mutations in diacylglycerol kinase epsilon","volume":"28","author":"Azukaitis","year":"2017","journal-title":"J Am Soc Nephrol"},{"key":"B28","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1093\/qjmed\/hcv082","article-title":"A national specialized service in England for atypical haemolytic uraemic syndrome-the first year\u2019s experience","volume":"109","author":"Sheerin","year":"2016","journal-title":"QJM"},{"key":"B29","doi-asserted-by":"publisher","first-page":"e146959","DOI":"10.1172\/jci.insight.146959","article-title":"Loss of diacylglycerol kinase epsilon causes thrombotic microangiopathy by impairing endothelial VEGFA signaling","volume":"6","author":"Liu","year":"2021","journal-title":"Jci Insight"},{"key":"B30","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1038\/nrneph.2014.250","article-title":"Podocyte dysfunction in atypical haemolytic uraemic syndrome","volume":"11","author":"Noris","year":"2015","journal-title":"Nat Rev Nephrol"},{"key":"B31","doi-asserted-by":"publisher","first-page":"110","DOI":"10.5414\/CNCS110534","article-title":"Thrombotic microangiopathy triggered by podocytopathy","volume":"9","author":"Verissimo","year":"2021","journal-title":"Clin Nephrol Case Stud"},{"key":"B32","doi-asserted-by":"publisher","first-page":"F284","DOI":"10.1152\/ajprenal.00002.2020","article-title":"Phosphorylation of key podocyte proteins and the association with proteinuric kidney disease","volume":"319","author":"Feng","year":"2020","journal-title":"Am J Physiol Renal Physiol"},{"key":"B33","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1111\/ped.12549","article-title":"Atypical hemolytic uremic syndrome: korean pediatric series","volume":"57","author":"Lee","year":"2015","journal-title":"Pediatr Int"},{"key":"B34","doi-asserted-by":"publisher","first-page":"1395","DOI":"10.1007\/s00467-018-3933-3","article-title":"Extra-renal manifestations of atypical hemolytic uremic syndrome in children","volume":"33","author":"Fidan","year":"2018","journal-title":"Pediatr Nephrol"},{"key":"B35","doi-asserted-by":"publisher","first-page":"1967","DOI":"10.1007\/s00467-014-2817-4","article-title":"An audit analysis of a guideline for the investigation and initial therapy of diarrhea negative (atypical) hemolytic uremic syndrome","volume":"29","author":"Johnson","year":"2014","journal-title":"Pediatr Nephrol"},{"key":"B36","doi-asserted-by":"publisher","first-page":"1337","DOI":"10.1007\/s00467-018-4039-7","article-title":"Extra-renal manifestations of atypical hemolytic uremic syndrome","volume":"34","author":"Formeck","year":"2019","journal-title":"Pediatr Nephrol"},{"key":"B37","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1007\/s00467-008-0964-1","article-title":"Guideline for the investigation and initial therapy of diarrhea-negative hemolytic uremic syndrome","volume":"24","author":"Ariceta","year":"2009","journal-title":"Pediatr Nephrol"},{"key":"B38","doi-asserted-by":"publisher","first-page":"1408","DOI":"10.1681\/ASN.2013080886","article-title":"Phenotypic expansion of DGKE-associated diseases","volume":"25","author":"Westland","year":"2014","journal-title":"J Am Soc Nephrol"},{"key":"B39","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1007\/s00467-015-3076-8","article-title":"An international consensus approach to the management of atypical hemolytic uremic syndrome in children","volume":"31","author":"Loirat","year":"2016","journal-title":"Pediatr Nephrol"},{"key":"B40","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1007\/s00467-014-3003-4","article-title":"Success of eculizumab in the treatment of atypical hemolytic uremic syndrome","volume":"30","author":"Baskin","year":"2015","journal-title":"Pediatr Nephrol"},{"key":"B41","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1016\/j.kint.2015.11.026","article-title":"Eculizumab is a safe and effective treatment in pediatric patients with atypical hemolytic uremic syndrome","volume":"89","author":"Greenbaum","year":"2016","journal-title":"Kidney Int"}],"container-title":["Frontiers in Pediatrics"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fped.2023.1162974\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,29]],"date-time":"2023-06-29T17:12:25Z","timestamp":1688058745000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fped.2023.1162974\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,29]]},"references-count":41,"alternative-id":["10.3389\/fped.2023.1162974"],"URL":"https:\/\/doi.org\/10.3389\/fped.2023.1162974","relation":{},"ISSN":["2296-2360"],"issn-type":[{"value":"2296-2360","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,6,29]]},"article-number":"1162974"}}